NovaSight has announced that it is running a large, pivotal multi-center randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for Amblyopia (Lazy Eye).
This is a content summary only. Visit us at https://infomeddnews.com
This is not a CAPTIS article. Originally, it was published here.